- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Twilio to add Segment in $3.2bn deal
GV is set to exit customer data management platform Segment in an all-share deal that more than doubles its valuation from 18 months ago.
Oct 12, 2020Kronos Bio crushes IPO to raise $250m
GV-backed cancer drug developer Kronos Bio floated above its range in an upsized offering and saw its shares soar in price post-IPO.
Oct 12, 2020Investors throw over $140m to 3DMed
Tigermed took part in a round that will support clinical progression of a 3D Medicines product pipeline that includes oncology candidate envafolimab.
Oct 12, 2020Flash Express hurries to $200m series D
The e-commerce delivery service doubled its total funding in a PTT-led round that included TCP subsidiary Durbell and Krungsri Finnovate.
Oct 12, 2020Galecto elects to target $100m in IPO
Merck Group, Bristol Myers-Squibb and Novo-backed cancer drug developer Galecto has filed to go public weeks after it last funding round.
Oct 12, 2020Spruce Bio ups IPO to $90m
Novo remains the largest shareholder in the endocrine disorder drug developer, which went public in an upsized offering.
Oct 12, 2020TigerConnect crafts $45m series D message
Relx and Telus-backed TigerConnect has now raised $149m in equity and debt financing for its healthcare messaging and collaboration platform.
Oct 12, 2020Wei waves goodbye to Sabic Ventures
John Wei, a GCV Emerging Leaders award winner this year, is departing from Sabic Ventures after six years.
Oct 12, 2020Evrythng tracks down $10m
You & Mr Jones put up a share of the funding as the consumer data technology provider took its overall funding to $60m.
Oct 12, 2020Analysis: 10x Genomics acquires ReadCoor for $350m
Eli Lilly is to exit the genetic sequencing system provider Readcoor in a cash-and-share acquisition by 10x Genomics. This is one of the relatively few exits we have seen in this space over the past decade.
Oct 12, 2020Angel Pharmaceuticals raises $41m to target China
Corvus spinoff Angel has secured series A funding from investors including Tigermed, Betta Pharmaceuticals and Hisun Pharmaceuticals.
Oct 10, 2020SBI snaps up TaoTao
Z Corporation has exited its 40% stake in crypto trading exchange TaoTao in an acquisition by SBI.
Oct 10, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
